Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CardioSeal Septal Occluder

Known as: CardioSeal Septal Occluders, Septal Occluders, CardioSeal, Septal Occluder, CardioSeal 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
AIMS Percutaneous patent foramen ovale (PFO) closure for secondary stroke prevention is discussed controversially. Long-term data… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Highly Cited
2008
Highly Cited
2008
This randomized trial compared procedural complications and 30-day clinical outcomes of 3 patent foramen ovale (PFO) closure… Expand
2008
2008
Transcatheter closure of patent foramen ovale (PFO) is a promising alternative to surgical closure or anticoagulation therapy in… Expand
Highly Cited
2004
Highly Cited
2004
Aims Interventional PFO closure has previously been reported to reduce the risk for recurrent thromboembolic events. The aim of… Expand
2004
2004
Abstract Background The Amplatzer septal occluder (ASO) allows the percutaneous closure of small to very large atrial septal… Expand
2004
2004
BACKGROUND The Amplatzer septal occluder (ASO) allows the percutaneous closure of small to very large atrial septal defects (ASDs… Expand
2002
2002
Two hundred and fifty-one patients with a persistent foramen ovale (PFO), mean age 43.3 +/- 12.4 years, underwent catheter… Expand
2002
2002
Two hundred and fifty-one patients with a persistent foramen ovale (PFO), mean age 43.3±12.4 years, underwent catheter closure… Expand
Highly Cited
2001
Highly Cited
2001
Paradoxical embolism through a patent foramen ovale (PFO) has been recognized as a potential cause of transient ischemia attack… Expand
Highly Cited
2001
Highly Cited
2001
BACKGROUND Atrial septal aneurysm is frequently associated with patent foramen ovale (PFO) and atrial septal defects (ASD… Expand